ImmunArray

ImmunArray is developing next-generation in-vitro diagnostic (IVD) tests for personalized medicine utilizing platform biomarker technology with a broad range of applications. Its first two products are blood tests for early diagnosis of lung cancer and detection and monitoring of heart attacks.  

IAL products are based on a breakthrough concept of mining the immune system for information about the body's condition. The company’s proprietary iCHIP system measures the repertoires of auto-antibodies in a drop of blood using microarray technology. The product comprises proprietary disposable chips and analytic software and uses standard fluorescent readers to read results.